Your browser doesn't support javascript.
loading
Clinical characteristics and survival in patients with heart failure experiencing in hospital cardiac arrest.
Aune, Emma; McMurray, John; Lundgren, Peter; Sattar, Naveed; Israelsson, Johan; Nordberg, Per; Herlitz, Johan; Rawshani, Araz.
Afiliação
  • Aune E; Institute of Medicine, University of Gothenburg, Gothenburg, Sweden. emma.aune@gu.se.
  • McMurray J; British Heart Foundation (BHF) Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Lundgren P; Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Sattar N; Prehospen-Centre for Prehospital Research, University of Borås, Borås, Sweden.
  • Israelsson J; British Heart Foundation (BHF) Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Nordberg P; Department of Internal Medicine, Division of Cardiology, Kalmar County Hospital, Region Kalmar County, Sweden.
  • Herlitz J; Faculty of Health and Life Sciences, Linnaeus University, Kalmar, Sweden.
  • Rawshani A; Department of Medicine, Center for Resuscitation Science, Karolinska Institute, Solna, Sweden.
Sci Rep ; 12(1): 5685, 2022 04 05.
Article em En | MEDLINE | ID: mdl-35383220
ABSTRACT
In patients with heart failure (HF) who suffered in-hospital cardiac arrest (IHCA), little is known about the characteristics, survival and neurological outcome. We used the Swedish Registry of Cardiopulmonary Resuscitation to study this, including patients aged ≥ 18 years suffering IHCA (2008-2019), categorised as HF alone, HF with acute myocardial infarction (AMI), AMI alone, or other. Odds ratios (OR) for 30-day survival, trends in 30-day survival, and the implication of HF phenotype was studied. 6378 patients had HF alone, 2111 had HF with AMI, 4210 had AMI alone. Crude 5-year survival was 9.6% for HF alone, 12.9% for HF with AMI and 34.6% for AMI alone. The 5-year survival was 7.9% for patients with HF and left ventricular ejection fraction (LVEF) ≥ 50%, 15.4% for LVEF < 40% and 12.3% for LVEF 40-49%. Compared with AMI alone, adjusted OR (95% CI) for 30-day survival was 0.66 (0.60-0.74) for HF alone, and 0.49 (0.43-0.57) for HF with AMI. OR for 30-day survival in 2017-2019 compared with 2008-2010 were 1.55 (1.24-1.93) for AMI alone, 1.37 (1.00-1.87) for HF with AMI and 1.30 (1.07-1.58) for HF alone. Survivors with HF had good neurological outcome in 92% of cases.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parada Cardíaca / Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Parada Cardíaca / Insuficiência Cardíaca Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article